Biofourmis vs Eleos Health
A detailed comparison to help you choose between Biofourmis and Eleos Health.
🏆
Verdict: Eleos Health wins
Eleos Health scores 4.1/5, edging out Biofourmis at 3.6/5. Community-based behavioral health and SUD organizations with 20+ clinicians that need documentation support and pre-submission compliance review inside an existing web-based EHR.
Biofourmis AI-powered patient monitoring and clinical insights for chronic disease management | Eleos Health AI-powered therapy insights through voice analysis | |
|---|---|---|
| Rating | 3.6 (1 review) | 4.1 (1 review) |
| Pricing Model | paid | paid |
| Starting Price | From $1000/mo | From $99/mo |
| Best For | Large health systems, IDNs and payers standing up hospital-at-home, post-acute or chronic-care monitoring programmes at scale who want FDA-cleared predictive analytics bundled with the clinical teams to act on it. | Community-based behavioral health and SUD organizations with 20+ clinicians that need documentation support and pre-submission compliance review inside an existing web-based EHR. |
| Free Tier | ||
| API Access | ||
| Team Features | ||
| Open Source | ||
| Tags | ssoteam features | gdpr compliantapi accessteam features |
| Visit Biofourmis → | Visit Eleos Health → |
Biofourmis
Pros
- + FDA-cleared analytics with Breakthrough Device Designation for BiovitalsHF — the strongest regulatory validation I have found in the RPM category.
- + The Biovitals engine models each patient against their own physiological baseline instead of population norms, which should meaningfully cut alert noise compared with threshold-based RPM (worth testing in any pilot).
- + It sells the escalation pathway with the software: virtual nursing, licensed navigators and in-home services (diagnostics, DME, meds, transport) orchestrated in one clinician dashboard — addressing the 2am-response gap that sinks most monitoring programmes.
- + Proven health-system deployments — AdventHealth acute care-at-home (January 2025), Lee Health hospital-at-home expansion (November 2024), plus UCI Health, Orlando Health, Augusta University Health and others named in company materials.
- + Device-agnostic sensor strategy with Epic EHR integration and a GE HealthCare partnership extending monitoring from hospital to home, so it fits existing clinical infrastructure rather than replacing it.
Cons
- - Zero commercial transparency: enterprise-only, no public pricing, custom contracts priced on patient volume and programme type — there is nothing to anchor a negotiation against.
- - The company has been through 120 layoffs (July 2023), a founder-CEO departure, an all-stock merger with CopilotIQ (October 2024) and a divestiture of its life-sciences arm (January 2025) — continuity risk on multi-year contracts.
- - Key performance claims (120+ biomarkers, deterioration detected days ahead, readmission reduction) are vendor-reported; I could not find independent head-to-head clinical evaluations.
- - No longer a clinical-trials vendor: biopharma buyers must now go to ActiGraph, which acquired Biofourmis Connect in January 2025.
- - It is a service-plus-software purchase — clinical staffing is embedded in the model, so the labour agreement carries as much delivery risk as the platform itself.
Eleos Health
Pros
- + EHR-agnostic browser-extension deployment means no API or HL7 integration project — in my walkthrough it sat on top of a web-based EHR with no custom build.
- + Compliance engine reviews 100% of notes against seven named checks (Uniqueness through Golden Thread) instead of the 5-10% sample rate manual QA teams manage.
- + Speech handling covers 150+ languages including mixed-language speech like Spanglish, which matches the bilingual caseloads common in community mental health.
- + 2026 agent additions (Eligibility Intelligence, Coding Agent) target revenue leakage upstream; early customers report 25% fewer Medicaid clients misclassified as uninsured.
- + Deep compliance posture: SOC 2, HITRUST, ISO 27001/27799/42001 certifications, HIPAA and FERPA compliance.
Cons
- - No self-serve signup, public pricing or free trial; market rates I found run $129/user/month (Documentation) and $119/user/month (Compliance) with $50k annual minimums (Indiana Council purchasing doc, May 2025).
- - Implementation fees in the $10,000-$30,000+ range make the product unreachable for small practices and solo clinicians.
- - Headline outcome stats (70% less admin time, 20% less turnover) are vendor-reported with no independent study I could find.
- - Vendor copy contradicts itself: the compliance page heads a '7-Point Compliance Analysis' but the body claims a 'six-point' review.
- - Group therapy documentation only shipped in September 2025, so that mode is much newer than the individual-session flow.
Frequently Asked Questions
Which is better, Biofourmis or Eleos Health?▼
Eleos Health scores higher at 4.1/5 vs 3.6/5 for Biofourmis, making it the better-rated option in our comparison.
What is the difference between Biofourmis and Eleos Health?▼
Biofourmis: Biofourmis runs remote patient monitoring and care-at-home programmes, combining wearable data with clinical analytics for health systems and life-science companies. Eleos Health: AI platform that analyzes therapy sessions through voice to provide real-time insights and improve mental health outcomes.
Is Biofourmis or Eleos Health more affordable?▼
Biofourmis starts at €1000/mo, Eleos Health starts at €99/mo. Check the comparison table above for current pricing.
Stay in the loop
Get weekly updates on the best new AI tools, deals, and comparisons.
No spam. Unsubscribe anytime.